Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer

Overview of attention for article published in Pathology & Oncology Research, December 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 4,673 followers.

📢 New to #Pathology and #Oncology Research! Researchers from @Uni_Szeged describe the benefits of oral #capecitabine in neoadjuvant #chemoradiotherapy for patients undergoing locally advanced #rectal #cancer surgery. Read the full article ⬇ https://t.co

RT @radonclibrary: Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy…

RT @radonclibrary: Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy…

RT @radonclibrary: Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.